1-(2-methylpropyl)-1H-imidazo[4,5-c][1, 5]naphthyridin-4-amine ethanesulfonate and 1-(2-methylpropyl)-1H-imidazo[4,5-c][1, 5]naphthyridin-4-amine methanesulfonate

Details for Australian Patent Application No. 2005323023 (hide)

Owner Takeda Pharmaceutical Company Limited

Inventors Tran, Tai T.; Jacobson, Joel R.; Skwierczynski, Raymond D.; Brostrom, Myles L.

Agent Phillips Ormonde Fitzpatrick

Pub. Number AU-A-2005323023

PCT Pub. Number WO2006/073939

Priority 60/708,636 16.08.05 US; 60/649,932 04.02.05 US; 60/698,416 12.07.05 US; 60/640,490 30.12.04 US

Filing date 28 December 2005

Wipo publication date 13 July 2006

International Classifications

C07D 471/14 (2006.01) Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups

A61K 31/44 (2006.01) - Non-condensed pyridines

Event Publications

23 August 2007 PCT application entered the National Phase

  PCT publication WO2006/073939 Priority application(s): WO2006/073939

14 January 2010 Application Lapsed, Refused Or Withdrawn, Patent Ceased or Expired

  This application lapsed under section 142(2)(a). A direction to request examination has been given for this application. Note that applications or patents shown as lapsed or ceased may be restored at a later date.

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2005323024-Multi-route administration of immune response modifier compounds

2005323021-Amusement ride